Vaginal Atrophy and Lichen Sclerosus: A Case Report

Lichen sclerosus (LS) is a benign, progressive, inflammatory disease characterized by epithelial thinning. An 81-year-old woman presented to our clinic with the complaint of difficulty in urination. There were whitish lesions on her vulva. Also, her urethra and vagina were obliterated with an approximately 2 mm opening. The diagnosis of LS was confirmed with pathological examination. Topical clobetasol propionate and estrogen treatment were prescribed. Three months later, the vagina had an approximately 1.5-cm diameter opening and there was no difficulty in urination. Such cases should be followed up concerning the progression of vulvar cancer.

🔖

Bu Makaleye Atıf Yap

ARINKAN, S. A., VURAL, F., GÜNEŞ, P. G., AKA, N. (2018). Vaginal Atrophy and Lichen Sclerosus: A Case Report. Haydarpaşa Numune Medical Journal, Cilt: 58 - Sayı: 2, 112–115. https://ajindex.com/articles/198201

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

McPherson T, Cooper S. Vulval lichen sclerosus and lichen planus. Dermatol Ther 2010;23:523–32. [CrossRef ] 2. Farrell AM, Millard Pr, Schomberg KH, Wojnarowska F. An infective aetiology for lichen sclerosus: Myth or reality? Br J Dermatol. 1997;137:25. 3. Neill SM, Staughton RCD, Lane EB, Leigh IM. The cytokeratin profile of normal vulval epithelium and vulval lichen sclerosus. Br J Dermatol 1990;123:62. [CrossRef ] 4. Thomas RH, Ridley CM, McGibbon DH, Black MM. Anogenital lichen sclerosus in women. J R Soc Med 1996;89:694–8. 5. Black MM, McKay M, Braude P. Color atlas andtext of obstetric and gynecologic dermatology. London; Mosby Wolfe; 1995. p. 119. 6. Uludag S, Mat C, Gezer A, Simsek A, Altınok T. Lichen Sclerosus Complicated by Vaginal Stenosis: Diagnosis and Management. J Turkish-German Gynecol Assoc 2008;9:176–8. 7. Ergin Ş. Lichen Sclerosus. Turk J Dermatol 2012;6:27–34. [CrossRef] 8. Thomas RH, Ridley CM, McGibbon DH, Black MM. Anogenital lichen sclerosus in women. J R Soc Med 1996;89:694–8. [CrossRef] 9. Virgili A, Borghi A, Toni G, Minghetti S, Corazza M. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability. Br J Dermatol 2014;171:388–96. 10. Funaro D, Lovett A, Leroux N, Powell J. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. J Am Acad Dermatol 2014;71:84–91. 11. Goldstein AT, Creasey A, Pfau R, Phillips D, Burrows LJ. A double- blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol 2011;64:e99–104. [CrossRef ] 12. Bracco GL, Carli P, Sonni L, Maestrini G, De Marco A, Taddei GL, et al. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation. J Reprod Med 1993;38:37–40. 13. Bornstein J, Heifetz S, Kellner Y, Stolar Z, Abramovici H. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998;178:80–4. [CrossRef ] 14. Cattaneo A, De Marco A, Sonni L, Bracco GL, Carli P, Taddei GL. Clobetasol vs. testosterone in the treatment of lichen sclerosus of the vulvar region. [Article in Italian]. Minerva Ginecol 1992;44:567–71. 15. Nair PA. Vulvar Lichen Sclerosus et Atrophicus. J Midlife Health 2017;8:55–62. [CrossRef ] 16. Mazdisn